Colostrum transfer of neutralizing antibodies against lumpy skin disease virus from vaccinated cows to their calves
Authors:
- Shawn BabiukSBShawn Babiuk
- Panagiotis-Dimitrios KatsoulosPanagiotis-Dimitrios Katsoulos
- Serafeim C. ChaintoutisSerafeim C. Chaintoutis
- Anastasia PraxitelousAPAnastasia Praxitelous
- Kaye QuizonKQKaye Quizon
- Constantinos BoscosCBConstantinos Boscos
- Zoe S. PolizopoulouZoe S. Polizopoulou
- Eleni D. ChondrokoukiECEleni D. Chondrokouki
- Chrysostomos I. DovasCDChrysostomos I. Dovas
Open Access
- 28 July 2018
- journal article
- research article
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 65 (6) , 2043-2048
Abstract
The objective of the present study was to access the titers and duration of maternally‐derived neutralizing antibodies against lumpy skin disease virus (LSDV) in calves born to immunized dairy cows. The study was conducted in a Greek farm of 200 Holstein cows which were immunized with a homologous Neethling strain‐based attenuated vaccine. Composite colostrum samples were obtained from 18 selected cows at the day of calving. Blood samples were obtained from each dam‐calf pair prior to the first colostrum feeding and from the calves successively on the third day after calving and on monthly intervals thereafter, until day 150. Passive transfer of antibodies in calves was evaluated by determining the levels of total protein in serum samples collected on day 3. Neutralizing antibody (NAb) titers against LSDV in colostrum and serum samples were determined by virus neutralization test. Colostrum NAb titers >1:160 were associated with the presence of NAbs in serum from calves 3 days after birth. Out of the 18 calves, which received colostrum with NAbs, 16 (88.9%) had detectable NAbs in their serum. Thereafter, a declining percentage of calves with detectable serum NAbs was recorded (38.5% on day 90 and 0% on days 120 and 150). Only calves with high NAb titers on day 3 had detectable serum NAbs until day 90 after calving. Thus, a significant number of calves were not protected by maternal antibodies against the disease after the age of 3 months and likely even after the age of 2 months. The findings of the present study substantiate that current recommendation for vaccination can be amended, so as to minimize the susceptible bovine population and enable optimized LSD prevention and eradication.Keywords
This publication has 27 references indexed in Scilit:
- Prospects of control and eradication of capripox from the Indian subcontinent: A perspectiveAntiviral Research, 2011
- Comparison of passive transfer of immunity in neonatal dairy calves fed colostrum or bovine serum-based colostrum replacement and colostrum supplement productsJournal of the American Veterinary Medical Association, 2010
- Detection of antibodies specific for sheeppox and goatpox viruses using recombinant capripoxvirus antigens in an indirect enzyme-linked immunosorbent assayJournal of Virological Methods, 2009
- Detection of Antibodies Against Capripoxviruses Using an Inactivated Sheeppox Virus ELISATransboundary and Emerging Diseases, 2009
- Capripoxviruses: An Emerging Worldwide Threat to Sheep, Goats and CattleTransboundary and Emerging Diseases, 2008
- Quantification of Lumpy Skin Disease Virus Following Experimental Infection in CattleTransboundary and Emerging Diseases, 2008
- Evaluation of 3 Assays for Failure of Passive Transfer in CalvesJournal of Veterinary Internal Medicine, 1996
- A new freeze-dried living virus vaccine against sheep-poxComparative Immunology, Microbiology and Infectious Diseases, 1979
- THE MECHANISM OF TRANSFER OF IMMUNOGLOBULIN INTO MAMMARY SECRETION OF COWSImmunology & Cell Biology, 1971
- The Antibody Response in Man Following Infection with Viruses of the Pox Group III. Antibody Response in SmallpoxEpidemiology and Infection, 1958